Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04824430 · ClinicalTrials.gov registry record
Assessment of Uterine Access, Uterine Patency and Intrauterine Adhesions Following Endometrial Ablation
A clinical trial of Intrauterine Adhesion, sponsored by Rejoni.
- Completed
- Registry status
- 36
- Enrollment target
- 1
- Study location
NCT04824430: Completed study of Intrauterine Adhesion, sponsored by Rejoni.
NCT04824430 is a study of Intrauterine Adhesion that has completed, run by Rejoni. The registered enrollment target is 36 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04824430, a study of Intrauterine Adhesion, has completed, sponsored by Rejoni.
- COMPLETED
- Registry status
- 36 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to gain information concerning the acute and longer-term morphological changes within the uterus following endometrial ablation. Hysteroscopic evaluation of the uterine cavity will be used to determine if physical access and the ability to systematically assess the post-ablation uterine cavity were preserved. The presence, location and severity of intrauterine adhesions will be documented in participants who are 3, 6 and 12 months from their standard of care endometrial ablation.
Conditions Studied
Study Locations (1)
Indiana
- Basinksi and Juran, MD's - Newburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2021-03-23 |
| Est. Completion | 2021-07-22 |
What the finished NCT04824430 record still lists
NCT04824430 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 36 participants, a relatively small participant target.
The record links to 1 condition, with Intrauterine Adhesion appearing as the primary indexed condition, and to 0 interventions.
NCT04824430 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT04824430 about?
NCT04824430 is a clinical study titled "Assessment of Uterine Access, Uterine Patency and Intrauterine Adhesions Following Endometrial Ablation". The objective of this study is to gain information concerning the acute and longer-term morphological changes within the uterus following endometrial ablation. Hysteroscopic evaluation of the uterine cavity will be used to determine if physical access and the ability to systematically assess the pos...
What is the current status of trial NCT04824430?
This trial is currently completed. The enrollment target is 36 participants. The study started on 2021-03-23. Estimated completion is 2021-07-22.
What conditions does trial NCT04824430 study?
This clinical trial studies the following conditions: Intrauterine Adhesion.
Who is sponsoring clinical trial NCT04824430?
This trial is sponsored by Rejoni, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04824430 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI